Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Takanobu, Teramura"'
Autor:
Hiroaki Iijima, Akihiro Sakai, Koji Ebisumoto, Go Ogura, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Takane Watanabe, Toshihide Inagi, Ryoko Yanagiya, Ai Yamamoto, Hiroshi Ashida, Yoshiyuki Ota, Yurina Sato, Naoya Kobayashi, Daisuke Maki, Naoya Nakamura, Kenji Okami
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Background: Recurrent or metastatic squamous cell carcinoma of the head and neck (R/MHNSCC) is a challenging malignancy with a poor prognosis and limited treatment options. Nivolumab, an immune checkpoint inhibitor (ICI) targeting the programmed cell
Externí odkaz:
https://doaj.org/article/f9e11e18f88743a487e81bbe064a545b
Autor:
Hiroaki Iijima, Akihiro Sakai, Koji Ebisumoto, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Toshihide Inagi, Kenji Okami
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-6 (2023)
Abstract Background Immune checkpoint inhibitors might cause immune-related adverse events that are still largely unknown. Case presentation An 80-year-old Asian female was diagnosed with cervical lymph node metastasis from lip cancer (cT1N0M0) and u
Externí odkaz:
https://doaj.org/article/e6a57d272a5f48668b1afc70a28dc3b9
Autor:
Akihiro Sakai, Koji Ebisumoto, Hiroaki Iijima, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Takane Watanabe, Toshihide Inagi, Daisuke Maki, Kenji Okami
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Objective This study aimed to evaluate the clinical effectiveness of chemotherapy following immune checkpoint inhibitors (ICI). The association between inflammatory and nutritional factors and prognosis has also been investigated. Methods We
Externí odkaz:
https://doaj.org/article/ab17ca163ec044e7ad86ac08125c606d
Autor:
Akihiro Sakai, Koji Ebisumoto, Hiroaki Iijima, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Takane Watanabe, Toshihide Inagi, Daisuke Maki, Kenji Okami
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 8, Iss 3, Pp 667-674 (2023)
Abstract Background Transoral salvage surgery has the potential to preserve a patient's quality of life. Therefore, we investigated the outcomes, safety, and risk factors for postoperative complications of salvage transoral videolaryngoscopic surgery
Externí odkaz:
https://doaj.org/article/0a972d5c068a45008f197accff2b520a
Autor:
Hiroaki Iijima, Kenji Okami, Akihiro Sakai, Takanobu Teramura, Aritomo Yamazaki, Toshihide Inagi, Koji Ebisumoto
Publikováno v:
Practica Oto-Rhino-Laryngologica. 116:367-370
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d275a66b5476ea43b7cb5e4290efbd29
https://doi.org/10.5631/jibirin.116.367
https://doi.org/10.5631/jibirin.116.367
Autor:
Akihiro Sakai, Koji Ebisumoto, Hiroaki Iijima, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Takane Watanabe, Toshihide Inagi, Daisuke Maki, Tsuyoshi Fukuzawa, Kenji Okami
Purpose This study assessed the efficacy of upfront neck dissection (ND) versus concurrent chemoradiotherapy (CRT) in patients diagnosed with T1–3N3 hypopharyngeal carcinoma (HPC).Methods This retrospective study enrolled patients with T1–3N3 HPC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b78692c6ad94085b5f75e774d96a4221
https://doi.org/10.21203/rs.3.rs-2882341/v1
https://doi.org/10.21203/rs.3.rs-2882341/v1
Autor:
Hiroaki IIJIMA, Kyoko ODAGIRI, Shohei YAMAMOTO, Tomoaki MURAKAMI, Atsushi UCHIYAMA, Yoshiyuki YAMADA, Toshihide INAGI, Takanobu TERAMURA, Kenji OKAMI, Masashi HAMADA
Publikováno v:
Tokai Journal of Experimental & Clinical Medicine; Jul2023, Vol. 48 Issue 2, p72-77, 6p
Autor:
Akihiro Sakai, Hiroaki Iijima, Koji Ebisumoto, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Takane Watanabe, Toshihide Inagi, Daisuke Maki, Kenji Okami
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2021
This study aimed to determine the prognostic value of inflammatory and nutritional biomarkers of immune checkpoint inhibitor (ICI) therapy for recurrent or metastatic squamous cell carcinoma of the head and neck (RMHNSCC) and to identify the most use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::befeedbb6a94cf5d7d641a1a3acabc04
https://doi.org/10.3390/cancers15072021
https://doi.org/10.3390/cancers15072021
Autor:
Hiroaki, Iijima, Akihiro, Sakai, Koji, Ebisumoto, Tomoaki, Murakami, Daisuke, Maki, Takanobu, Teramura, Mayu, Yamauchi, Aritomo, Yamazaki, Toshihide, Inagi, Kenji, Okami
Publikováno v:
The Tokai journal of experimental and clinical medicine. 47(3)
In December 2019, pembrolizumab was approved in Japan for the treatment of head and neck cancer with recurrence or distant metastasis, making it a new option for first-line treatment. However, there are still many unanswered questions about Overall s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8843d82fa40b8508ba67f477234a7b05
https://pubmed.ncbi.nlm.nih.gov/36073278
https://pubmed.ncbi.nlm.nih.gov/36073278
Autor:
Masahiro Iida, Motoki Sekine, Kosuke Saito, Fumiyuki Goto, Tomoaki Murakami, Takanobu Teramura, Kenji Okami
Publikováno v:
Equilibrium Research. 78:562-566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b817f40dd7235f9ba7789c12df65e5d3
https://doi.org/10.3757/jser.78.562
https://doi.org/10.3757/jser.78.562